Obesity Clinical Trial
Korean red ginseng (KRG) is popular worldwide since it is believed to contain ingredients with a variety of health enhancement effects. Several in vitro studies and animal studies showed that ginseng has anti-obesity, anti-diabetic and anti-metabolic disease effects. Several studies involving type 2 diabetes mellitus (T2DM) patients reported that administration of KRG for 12 weeks resulted in positive effects on the maintenance of sugar control effect and improvement of insulin resistance Although there is evidence to suggest that KRG could efficacious reduction in postprandial glycemia, the benefits of long-term KRG in healthy individuals on insulin sensitivity has not yet been established. Therefore, we investigated whether KRG affected insulin sensitivity in healthy overweight or obese Korean subjects without overt diabetes.
80 adults between the ages of 20 and 60 years and with a BMI ≥ 23 kg/m2 was initially
enrolled. The subjects had not taken any supplements or medications, including anti-diabetic
drugs, anti-hypertensive drugs, steroids, or hormonal products, during the previous 4 weeks.
This study had a randomized, placebo-controlled, double-blind controlled design. Each
subject was randomized to either the Intervention group or the Control group. The subjects
in the Intervention group were administered with 4 capsules (2 g) each of powdered red
ginseng (6-year old , rootlets) 40 minutes before breakfast, lunch and dinner, totaling 12
capsules (6 g) per day, for 12 weeks. The subjects in the Control group were given the same
quantity of placebos also three times a day for 12 weeks.
Blood samples after a 12-h fast were taken at baseline and 12 weeks after randomization.
Blood samples were taken after at least 8 hours of fasting for general blood test,
biochemical test and lipid test. Each subject's diet was monitored by a semi-quantitative
FFQ at baseline and after 12 weeks. Participants were asked to report the frequency of
consumption of 53 food items contained in the semi-quantitative FFQ over the 2 weeks prior
to administration by an experienced dietitian. Excessive drinking was defined according to
the guidelines of the National Institute Alcohol Abuse and Alcoholism when more than 14
glasses (alcohol 196 g) are consumed for male and 7 glasses (alcohol 98 g) for female.
Physical activity was assessed using the International Physical Activity Questionnaire at
baseline and after 12 weeks. We expressed physical activity levels as MET-minute. METs are
multiples of the resting metabolic rates. A MET-minute is computed by multiplying the MET
score of an activity by the minutes performed. MET-minute scores are equivalent to
kilocalories for a 60 kilogram person.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |